Cite
APA Citation
Sun, W., Patel, A., Normolle, D., Patel, K., Ohr, J., Lee, J. J., Bahary, N., Chu, E., Streeter, N., & Drummond, S. (2019). a phase 2 trial of regorafenib as a single agent in patients with chemotherapy‐refractory, advanced, and metastatic biliary tract adenocarcinoma. Cancer, 125(6), 902–909. http://access.bl.uk/ark:/81055/vdc_100077990169.0x00005f